DX9065a, an Xa inhibitor, inhibits prothrombin-induced A549 lung adenocarcinoma cell proliferation

Cancer Letters

Volumn 122, Issue 1-2, 1998, Pages 127-133

  Nakata, Masanori ^a   Kanekura, Shoko ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cancer procoagulant; DX9065a; Thrombin

Indexed keywords

2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; ANTIMITOTIC AGENT; BLOOD CLOTTING FACTOR 10A; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTHROMBIN; THROMBIN; THROMBIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MITOGENESIS; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTICOAGULANTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CELL DIVISION; FACTOR XA; HUMANS; NAPHTHALENES; PROPIONIC ACIDS; PROTEIN KINASE C; PROTHROMBIN; TUMOR CELLS, CULTURED;

OXY;

EID: 0032498258     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00379-0     Document Type: Article

References (22)

1. Jackson C.M., Nemerson Y. Blood coagulation. Annu. Rev. Biochem. 49:1980;765-811.
2. McNamara C.A., Sarembock I.J., Gimple L.W., Fenton J.W., Coughlin S.R., Owens G.K. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91:1993;94-98.
3. Chambard J.C., Paris S., L'Allemain G., Pouyssegur J. Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin. Nature. 326:1987;800-803.
4. Vu T.K., Hung D.T., Wheaton V.I., Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068.
5. Nesheim M.E., Taswell J.B., Mann K.G. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J. Biol. Chem. 254:1979;10952-10962.
6. Sekiya F., Usui H., Inoue K., Fukudome K., Morita T. Activation of prothrombin by a novel membrane-associated protease. An alternative pathway for thrombin generation independent of the coagulation cascade. J. Biol. Chem. 269:1994;32441-32445.
7. Seitz R., Heidtmann H.H., Maasberg M., Immel A., Egbring R., Havemann K. Activators of coagulation in cultured human lung-tumor cells. Int. J. Cancer. 53:1993;514-520.
8. Maruyama I., Majerus P.W. The turnover of thrombin-thrombomodulin complex in cultured human umbilical vein endothelial cells and A549 lung cancer cells. Endocytosis and degradation of thrombin. J. Biol. Chem. 260:1985;15432-15438.
9. Hara T., Yokoyama A., Ishihara H., Yokoyama Y., Nagahara T., Iwamoto M. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa. Thromb. Haemost. 71:1994;314-319.
10. Richards W.L., Song M.K., Krutzsch H., Evarts R.P., Marsden E., Thorgeirsson S.S. Measurement of cell proliferation in microculture using Hoechst 33342 for the rapid semiautomated microfluorimetric determination of chromatin DNA. Exp. Cell. Res. 159:1985;235-246.
11. Yada T., Sakurada M., Ihida K., Nakata M., Murata F., Arimura A., Kikuchi M. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J. Biol. Chem. 269:1994;1290-1293.
12. Shin H., Nakajima T., Kitajima I., Shigeta K., Abeyama K., Imamura T., Okano T., Kawahara K., Nakamura T., Maruyama I. Thrombin receptor-mediated synovial proliferation in patients with rheumatoid arthritis. Clin. Immunol. Immunopathol. 76:1995;225-233.
13. Maruyama Y., Maruyama I., Soejima Y. Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 199:1994;1262-1269.
14. Huang R.S., Sorisky A., Church W.R., Simons E.R., Rittenhouse S.E. 'Thrombin' receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides. J. Biol. Chem. 266:1991;18435-18438.
15. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
16. Dvorak H.F. Thrombosis and cancer. Hum. Pathol. 18:1987;275-284.
17. Dvorak H.M. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1986;1650-1659.
18. Liu L., Rodgers G.M. Characterization of an inducible endothelial cell prothrombin activator. Blood. 88:1996;2989-2994.
19. Tokumoto H., Croxtall J.D., Choudhury Q., Flower R.J. Phospholipase A2-induced stimulation of A549 lung adenocarcinoma cell line proliferation. Biochem. Biophys. Acta. 1169:1993;236-242.
20. Tokumoto H., Croxtall J.D., Flower R.J. Differential role of extra- and intracellular calcium in bradykinin and interleukin 1 alpha stimulation of arachidonic acid release from A549 cells. Biochem. Biophys. Acta. 1211:1994;301-309.
21. Kang Y.H., Kedar V.P., Maheshwari R.K. Thrombin stimulation of synthesis and secretion of fibronectin by human A549 epithelial cells and mouse LB fibroblasts. J. Histochem. Cytochem. 39:1991;413-423.
22. Gordon S.G., Cross B.A. A factor X-activating cysteine protease from malignant tissue. J. Clin. Invest. 67:1981;1665-1671.